1. PO-0750: Conventionally-fractionated VMAT vs. SBRT in prostate cancer:PSA kinetics, toxicity, quality of life. (April 2016) Authors: Tambas, M.; Agaoglu, F.; Iribas, A.; Guveli, M.; Dizdar, Y.; Okutan, M.; Ozkan, D.; Tenekeci, N.; Darendeliler, E. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗